Meta and Other Tech Companies Ban OpenClaw Over Cybersecurity Concerns

Security experts have urged people to be cautious with the viral agentic AI tool, known for being highly capable but also wildly unpredictable.

CFO Inertia To Cost Brands 34% Of Profits By 2030, Says Climate Report

The report projects a 3% climate-cost shock that could erase a third of profits, and high-risk scenarios could push losses to 67%, urging fashion brands to decarbonize.

‘A Knight Of The Seven Kingdoms’ Divides Fans With Controversial New Episode

Some Knight Of The Seven Kingdoms fans are very upset over the most recent episode. This is why – and why they’re wrong.

AHRQ Revives After Death-By-DOGE Threat, But What Will New Leaders Do?

AHRQ, the federal agency charged with improving health care quality and safety, has staved off death, but it remains unclear what new leadership will do.

iOS 26.4—Apple Switches Key iPhone Feature On By Default

Apple’s iOS 26.4 sees its Stolen Device Protection anti-theft feature turned on by default. Here’s what you need to know.

Shein’s ‘addictive design’ and illegal sex dolls under investigation
Shein’s ‘addictive design’ and illegal sex dolls under investigation

The European Union has opened a formal investigation into Shein after French regulators found listings for “child-like sex dolls” on the retail platform last year. The investigation will assess whether the systems Shein is using to curb illegal product sales are compliant with the EU’s Digital Services Act (DSA), according to the European Commission, including […]

A New Tech Solution To The Freight Fraud Problem

Digital freight fraud is a multibillion-dollar problem that has been growing quickly. But a new technology solution has arrived that will take a big bite out of fraud.

The Geopolitics Of The Green Transition Changes How Power Accumulates

The green transition is reshaping global power: mineral-rich countries like China and the DRC now control critical materials for batteries, magnets, and grids.

Gene Editing Has Struggled To Go Commercial. This Nobel Laureate Has A $1 Billion Plan To Fix That.

Crispr’s ability to cut genetic code like scissors has just started to turn into medicines. Now, gene editing pioneer Jennifer Doudna wants to build an entire ecosystem to bring these treatments mainstream.